ADAP
Adaptimmune Therapeutics
ADAP
ADAP
78 hedge funds and large institutions have $115M invested in Adaptimmune Therapeutics in 2023 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 15 increasing their positions, 26 reducing their positions, and 14 closing their positions.
Holders
78
Holders Change
–
Holders Change %
0%
% of All Funds
1.14%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
14
Increased
15
Reduced
26
Closed
14
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–